ADMINISTRATION PAR VOIES AERIENNES DE L'INHIBITEUR DE LA VOIE DU FACTEUR TISSULAIRE DANS DES CONDITIONS INFLAMMATOIRES AFFECTANT LES VOIES RESPIRATOIRES
The present invention provides methods for the local treatment of acute and chronic extravascular pulmonary fibrin deposition and/or reducing unwanted effects associated with systemic administration of natural anticoagulants to a subject via airway administration to the subject by intratracheal, intrabronchial or intraalveolar routes of natural anticoagulants or biologically active derivatives thereof.